[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"biomarker:plasma-biomarker":3},{"name":4,"total":5,"recruiting":5,"trials":6},"Plasma biomarker",1,[7],{"nct_id":8,"title":9,"phases":10,"status":12,"updated_at":13,"content_modified":14},"NCT07011745","A Phase 3 Study to Evaluate the Safety and Efficacy of KarXT + KarX-EC for the Treatment of Agitation Associated With Alzheimer's Disease",[11],"Phase 3","RECRUITING","2026-08-26T02:15:36.077529Z","2026-07-30T01:46:14.435459Z"]